Indefinite Delivery Contract SPE2DX15D1007

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention.

The contract, which has an ultimate completion date of December 31, 2025, does not have any set-aside designations, indicating open competition. The DLA has issued numerous delivery orders under this IDC for various pharmaceutical and medical commodities, including Tobrex eye ointment, acetaminophen-codeine tablets, procainamide vials, and atropine vials, among others. The orders are firm fixed price with places of performance in Conshohocken, Pennsylvania. This IDC demonstrates Amerisourcebergen's critical role in supplying essential medical products to the U.S. federal government, particularly the Department of Defense and its military healthcare system.